 DERMADEX
|
GlaxoSmithKline Biopharma
|
| clobetasol |
Antieccematoso |
| cr.x 15 g | $21.063,32 | (30/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $8.425,33 AF $12.637,99 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $16.064,70 |
|
|
|
|
| cr.x 30 g | $41.307,44 | (30/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $16.522,98 AF $24.784,46 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $35.379,19 |
|
|
|
|
| ung.x 15 g | $19.961,49 | (30/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $7.984,60 AF $11.976,89 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $14.962,87 |
|
|
|
|
| ung.x 30 g | $38.258,08 | (30/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $15.303,23 AF $22.954,85 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $32.329,83 |
|
|
|
|
| |
